Get the Stockscreener App
0.5358
0.19%
0.001
After Hours:
.54
0.0042
+0.78%
Rallybio Corp stock is traded at $0.5358, with a volume of 211.90K.
It is up +0.19% in the last 24 hours and down -9.71% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.5348
Open:
$0.54
24h Volume:
211.90K
Relative Volume:
0.51
Market Cap:
$22.39M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.2925
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
-6.93%
1M Performance:
-9.71%
6M Performance:
+104.58%
1Y Performance:
-50.84%
1-Day Range:
$0.5209
$0.56
1-Week Range:
$0.49
$0.59
52-Week Range:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.5358 | 22.35M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Will Rallybio Corporation stock beat EPS estimatesJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Risk adjusted return profile for Rallybio Corporation analyzedGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com
How Rallybio Corporation stock performs in rising dollar environmentWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Analyzing Rallybio Corporation with risk reward ratio chartsJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Is Rallybio Corporation stock reversal real or fake2025 Valuation Update & Precise Buy Zone Identification - newser.com
Rallybio (NASDAQ:RLYB) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Rallybio Corporation stock outlook for YEAR2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Best data tools to analyze Rallybio Corporation stockGap Up & Weekly High Conviction Ideas - newser.com
What Fibonacci levels say about Rallybio Corporation rebound2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Is Rallybio Corporation stock attractive for growth ETFsWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com
Rallybio Corporation (NASDAQ:RLYB) Short Interest Update - Defense World
Will Rallybio Corporation stock benefit from automation2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Is it too late to sell Rallybio Corporation2025 Winners & Losers & Verified Technical Signals - newser.com
Analysts Set Rallybio Corporation (NASDAQ:RLYB) PT at $5.00 - Defense World
Using data tools to time your Rallybio Corporation exit2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Can Rallybio Corporation stock deliver sustainable ROEQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Top chart patterns to watch in Rallybio CorporationMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Rallybio Corporation Stock Analysis and ForecastMarket Capitalization Trends & You’ll Regret Not Buying These Early - earlytimes.in
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug - MSN
Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study By Investing.com - Investing.com Nigeria
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.09%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):